Endocannabinoid Signaling and Synaptic Function

Neuron

Volumn 76, Issue 1, 2012, Pages 70-81

  Castillo, Pablo E ^a   Younts, Thomas J ^a   Chávez, Andrés E ^a   Hashimotodani, Yuki ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR; ENDOCANNABINOID;

BEHAVIOR; BRAIN NERVE CELL; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; DEPOLARIZATION; GLIA; HUMAN; LONG TERM DEPRESSION; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNTHESIS;

ANIMALS; BRAIN; ENDOCANNABINOIDS; HUMANS; NEURONAL PLASTICITY; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84867113185     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2012.09.020     Document Type: Review

References (160)

1. Ade K.K., Lovinger D.M. Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. J. Neurosci. 2007, 27:2403-2409.
2. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
3. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 2002, 68:247-286.
4. Alger B.E. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J. Physiol. 2012, 590:2203-2212.
5. Auclair N., Otani S., Soubrie P., Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 2000, 83:3287-3293.
6. Bacci A., Huguenard J.R., Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 2004, 431:312-316.
7. Banni S., Di Marzo V. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol. Nutr. Food Res. 2010, 54:82-92.
8. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277:1094-1097.
9. Bender V.A., Bender K.J., Brasier D.J., Feldman D.E. Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J. Neurosci. 2006, 26:4166-4177.
10. Blankman J.L., Simon G.M., Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14:1347-1356.
11. Brenowitz S.D., Regehr W.G. Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 2005, 45:419-431.
12. Brown S.P., Brenowitz S.D., Regehr W.G. Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat. Neurosci. 2003, 6:1048-1057.
13. Caiati M.D., Sivakumaran S., Lanore F., Mulle C., Richard E., Verrier D., Marsicano G., Miles R., Cherubini E. Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses. Sci. Rep. 2012, 2:285.
14. Carriba P., Navarro G., Ciruela F., Ferré S., Casadó V., Agnati L., Cortés A., Mallol J., Fuxe K., Canela E.I., et al. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods 2008, 5:727-733.
15. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 2001, 24:487-517.
16. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
17. Cavanaugh D.J., Chesler A.T., Jackson A.C., Sigal Y.M., Yamanaka H., Grant R., O'Donnell D., Nicoll R.A., Shah N.M., Julius D., Basbaum A.I. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J. Neurosci. 2011, 31:5067-5077.
18. Chanda P.K., Gao Y., Mark L., Btesh J., Strassle B.W., Lu P., Piesla M.J., Zhang M.Y., Bingham B., Uveges A., et al. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol. Pharmacol. 2010, 78:996-1003.
19. Chávez A.E., Chiu C.Q., Castillo P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci. 2010, 13:1511-1518.
20. Chen K., Ratzliff A., Hilgenberg L., Gulyás A., Freund T.F., Smith M., Dinh T.P., Piomelli D., Mackie K., Soltesz I. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 2003, 39:599-611.
21. Chen K., Neu A., Howard A.L., Földy C., Echegoyen J., Hilgenberg L., Smith M., Mackie K., Soltesz I. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 2007, 27:46-58.
22. Chen M., Wan Y., Ade K., Ting J., Feng G., Calakos N. Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J. Neurosci. 2011, 31:9563-9573.
23. Chevaleyre V., Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 2003, 38:461-472.
24. Chevaleyre V., Castillo P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 2004, 43:871-881.
25. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 2006, 29:37-76.
26. Chevaleyre V., Heifets B.D., Kaeser P.S., Südhof T.C., Castillo P.E. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron 2007, 54:801-812.
27. Chiu C.Q., Puente N., Grandes P., Castillo P.E. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 2010, 30:7236-7248.
28. Coutts A.A., Anavi-Goffer S., Ross R.A., MacEwan D.J., Mackie K., Pertwee R.G., Irving A.J. Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J. Neurosci. 2001, 21:2425-2433.
29. Cristino L., de Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
30. Cristino L., Starowicz K., De Petrocellis L., Morishita J., Ueda N., Guglielmotti V., Di Marzo V. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 2008, 151:955-968.
31. Crosby K.M., Inoue W., Pittman Q.J., Bains J.S. Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron 2011, 71:529-541.
32. De Chiara V., Angelucci F., Rossi S., Musella A., Cavasinni F., Cantarella C., Mataluni G., Sacchetti L., Napolitano F., Castelli M., et al. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J. Neurosci. 2010, 30:8127-8137.
33. De Petrocellis L., Di Marzo V. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J. Neuroimmune Pharmacol. 2010, 5:103-121.
34. den Boon F.S., Chameau P., Schaafsma-Zhao Q., van Aken W., Bari M., Oddi S., Kruse C.G., Maccarrone M., Wadman W.J., Werkman T.R. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc. Natl. Acad. Sci. USA 2012, 109:3534-3539.
35. Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res. 2009, 60:77-84.
36. Di Marzo V. Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat. Neurosci. 2011, 14:9-15.
37. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., Bisogno T. Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:377-391.
38. DiPatrizio N.V., Piomelli D. The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci. 2012, 35:403-411.
39. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgänsberger W., Lutz B., Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 2006, 26:5794-5799.
40. Dong X.P., Wang X., Xu H. TRP channels of intracellular membranes. J. Neurochem. 2010, 113:313-328.
41. Edwards D.A., Zhang L., Alger B.E. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc. Natl. Acad. Sci. USA 2008, 105:8142-8147.
42. Egertová M., Simon G.M., Cravatt B.F., Elphick M.R. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. J. Comp. Neurol. 2008, 506:604-615.
43. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
44. Fu J., Bottegoni G., Sasso O., Bertorelli R., Rocchia W., Masetti M., Guijarro A., Lodola A., Armirotti A., Garau G., et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat. Neurosci. 2012, 15:64-69.
45. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., Shen R., Zhang M.Y., Strassle B.W., Lu P., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30:2017-2024.
46. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 2002, 5:446-451.
47. Gibson H.E., Edwards J.G., Page R.S., Van Hook M.J., Kauer J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008, 57:746-759.
48. Gomez O., Arevalo-Martin A., Garcia-Ovejero D., Ortega-Gutierrez S., Cisneros J.A., Almazan G., Sánchez-Rodriguez M.A., Molina-Holgado F., Molina-Holgado E. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation. Glia 2010, 58:1913-1927.
49. Grueter B.A., Brasnjo G., Malenka R.C. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat. Neurosci. 2010, 13:1519-1525.
50. Gulyas A.I., Cravatt B.F., Bracey M.H., Dinh T.P., Piomelli D., Boscia F., Freund T.F. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci. 2004, 20:441-458.
51. Han J., Kesner P., Metna-Laurent M., Duan T., Xu L., Georges F., Koehl M., Abrous D.N., Mendizabal-Zubiaga J., Grandes P., et al. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 2012, 148:1039-1050.
52. Harkany T., Mackie K., Doherty P. Wiring and firing neuronal networks: endocannabinoids take center stage. Curr. Opin. Neurobiol. 2008, 18:338-345.
53. Hashimotodani Y., Ohno-Shosaku T., Tsubokawa H., Ogata H., Emoto K., Maejima T., Araishi K., Shin H.S., Kano M. Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
54. Hashimotodani Y., Ohno-Shosaku T., Kano M. Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr. Opin. Neurobiol. 2007, 17:360-365.
55. Hashimotodani Y., Ohno-Shosaku T., Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J. Neurosci. 2007, 27:1211-1219.
56. Hegyi Z., Holló K., Kis G., Mackie K., Antal M. Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats. Glia 2012, 60:1316-1329.
57. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 2009, 71:283-306.
58. Heifets B.D., Chevaleyre V., Castillo P.E. Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc. Natl. Acad. Sci. USA 2008, 105:10250-10255.
59. Hentges S.T., Low M.J., Williams J.T. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J. Neurosci. 2005, 25:9746-9751.
60. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 1990, 87:1932-1936.
61. Hill E.L., Gallopin T., Férézou I., Cauli B., Rossier J., Schweitzer P., Lambolez B. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J. Neurophysiol. 2007, 97:2580-2589.
62. Hillard C.J., Edgemond W.S., Jarrahian A., Campbell W.B. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 1997, 69:631-638.
63. Hillard C.J., Weinlander K.M., Stuhr K.L. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 2012, 204:207-229.
64. Hoffman A.F., Laaris N., Kawamura M., Masino S.A., Lupica C.R. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci. 2010, 30:545-555.
65. Howlett A.C. Cannabinoid receptor signaling. Handb. Exp. Pharmacol. 2005, 168:53-79.
66. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
67. Huang Y., Yasuda H., Sarihi A., Tsumoto T. Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice. J. Neurosci. 2008, 28:7074-7083.
68. Hudson B.D., Hébert T.E., Kelly M.E. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor. Mol. Pharmacol. 2010, 77:1-9.
69. Jin W., Brown S., Roche J.P., Hsieh C., Celver J.P., Kovoor A., Chavkin C., Mackie K. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 1999, 19:3773-3780.
70. Kang-Park M.H., Wilson W.A., Kuhn C.M., Moore S.D., Swartzwelder H.S. Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats. J. Neurophysiol. 2007, 98:1223-1230.
71. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
72. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
73. Katona I., Sperlágh B., Sík A., Käfalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 1999, 19:4544-4558.
74. Katona I., Urbán G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 2006, 26:5628-5637.
75. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 2006, 26:2991-3001.
76. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat. Neurosci. 2010, 13:592-600.
77. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
78. Lafourcade M., Elezgarai I., Mato S., Bakiri Y., Grandes P., Manzoni O.J. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2007, 2:e709.
79. Lafourcade M., Larrieu T., Mato S., Duffaud A., Sepers M., Matias I., De Smedt-Peyrusse V., Labrousse V.F., Bretillon L., Matute C., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14:345-350.
80. Lerner T.N., Kreitzer A.C. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 2012, 73:347-359.
81. Ligresti A., Petrosino S., Di Marzo V. From endocannabinoid profiling to 'endocannabinoid therapeutics'. Curr. Opin. Chem. Biol. 2009, 13:321-331.
82. Liu J., Wang L., Harvey-White J., Huang B.X., Kim H.Y., Luquet S., Palmiter R.D., Krystal G., Rai R., Mahadevan A., et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 2008, 54:1-7.
83. Losonczy A., Biró A.A., Nusser Z. Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc. Natl. Acad. Sci. USA 2004, 101:1362-1367.
84. Lourenço J., Cannich A., Carta M., Coussen F., Mulle C., Marsicano G. Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. Nat. Neurosci. 2010, 13:197-204.
85. Ludányi A., Eross L., Czirják S., Vajda J., Halász P., Watanabe M., Palkovits M., Maglóczky Z., Freund T.F., Katona I. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 2008, 28:2976-2990.
86. Ludányi A., Hu S.S., Yamazaki M., Tanimura A., Piomelli D., Watanabe M., Kano M., Sakimura K., Maglóczky Z., Mackie K., et al. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 2011, 174:50-63.
87. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 2008, 11:152-159.
88. Mackie K. Cannabinoid receptor homo- and heterodimerization. Life Sci. 2005, 77:1667-1673.
89. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
90. Maejima T., Oka S., Hashimotodani Y., Ohno-Shosaku T., Aiba A., Wu D., Waku K., Sugiura T., Kano M. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J. Neurosci. 2005, 25:6826-6835.
91. Marinelli S., Pacioni S., Bisogno T., Di Marzo V., Prince D.A., Huguenard J.R., Bacci A. The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J. Neurosci. 2008, 28:13532-13541.
92. Marinelli S., Pacioni S., Cannich A., Marsicano G., Bacci A. Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat. Neurosci. 2009, 12:1488-1490.
93. Marrs W.R., Blankman J.L., Horne E.A., Thomazeau A., Lin Y.H., Coy J., Bodor A.L., Muccioli G.G., Hu S.S., Woodruff G., et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci. 2010, 13:951-957.
94. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
95. Massa F., Mancini G., Schmidt H., Steindel F., Mackie K., Angioni C., Oliet S.H., Geisslinger G., Lutz B. Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J. Neurosci. 2010, 30:6273-6281.
96. Mato S., Chevaleyre V., Robbe D., Pazos A., Castillo P.E., Manzoni O.J. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 2004, 7:585-586.
97. Mato S., Lafourcade M., Robbe D., Bakiri Y., Manzoni O.J. Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. Neuropharmacology 2008, 54:87-94.
98. Mechoulam R., Parker L.A. The endocannabinoid system and the brain. Annu Rev Psychol. 2012, Published online July 12, 2012. 10.1146/annurev-psych-113011-143739.
99. Mezey E., Tóth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. USA 2000, 97:3655-3660.
100. Mikasova L., Groc L., Choquet D., Manzoni O.J. Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc. Natl. Acad. Sci. USA 2008, 105:18596-18601.
101. Min R., Nevian T. Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat. Neurosci. 2012, 15:746-753.
102. Navarrete M., Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008, 57:883-893.
103. Navarrete M., Araque A. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 2010, 68:113-126.
104. Neu A., Földy C., Soltesz I. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J. Physiol. 2007, 578:233-247.
105. Nevian T., Sakmann B. Spine Ca2+ signaling in spike-timing-dependent plasticity. J. Neurosci. 2006, 26:11001-11013.
106. Nomura S., Fukaya M., Tsujioka T., Wu D., Watanabe M. Phospholipase Cbeta3 is distributed in both somatodendritic and axonal compartments and localized around perisynapse and smooth endoplasmic reticulum in mouse Purkinje cell subsets. Eur. J. Neurosci. 2007, 25:659-672.
107. Nomura D.K., Morrison B.E., Blankman J.L., Long J.Z., Kinsey S.G., Marcondes M.C., Ward A.M., Hahn Y.K., Lichtman A.H., Conti B., Cravatt B.F. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 2011, 334:809-813.
108. Nyilas R., Dudok B., Urbán G.M., Mackie K., Watanabe M., Cravatt B.F., Freund T.F., Katona I. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J. Neurosci. 2008, 28:1058-1063.
109. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
110. Okamoto Y., Wang J., Morishita J., Ueda N. Biosynthetic pathways of the endocannabinoid anandamide. Chem. Biodivers. 2007, 4:1842-1857.
111. Oliet S.H., Baimoukhametova D.V., Piet R., Bains J.S. Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J. Neurosci. 2007, 27:1325-1333.
112. Pan B., Hillard C.J., Liu Q.S. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci. 2008, 28:14018-14030.
113. Pan B., Wang W., Zhong P., Blankman J.L., Cravatt B.F., Liu Q.S. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J. Neurosci. 2011, 31:13420-13430.
114. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
115. 2. Pharmacol. Rev. 2010, 62:588-631.
116. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
117. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr. Opin. Investig. Drugs 2005, 6:672-679.
118. Puente N., Cui Y., Lassalle O., Lafourcade M., Georges F., Venance L., Grandes P., Manzoni O.J. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci. 2011, 14:1542-1547.
119. Regehr W.G., Carey M.R., Best A.R. Activity-dependent regulation of synapses by retrograde messengers. Neuron 2009, 63:154-170.
120. Riebe C.J., Wotjak C.T. Endocannabinoids and stress. Stress 2011, 14:384-397.
121. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 2002, 99:8384-8388.
122. Roberts J.C., Davis J.B., Benham C.D. [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 2004, 995:176-183.
123. Roloff A.M., Anderson G.R., Martemyanov K.A., Thayer S.A. Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity. J. Neurosci. 2010, 30:3072-3081.
124. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J. Neurosci. 2008, 28:7284-7292.
125. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 2001, 22:565-572.
126. Schlosburg J.E., Blankman J.L., Long J.Z., Nomura D.K., Pan B., Kinsey S.G., Nguyen P.T., Ramesh D., Booker L., Burston J.J., et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 2010, 13:1113-1119.
127. Singla S., Kreitzer A.C., Malenka R.C. Mechanisms for synapse specificity during striatal long-term depression. J. Neurosci. 2007, 27:5260-5264.
128. Sjöström P.J., Turrigiano G.G., Nelson S.B. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 2003, 39:641-654.
129. Slanina K.A., Schweitzer P. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 2005, 49:653-659.
130. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 2000, 129:227-230.
131. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009, 56(Suppl 1):244-253.
132. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010, 58:1017-1030.
133. Szabo B., Urbanski M.J., Bisogno T., Di Marzo V., Mendiguren A., Baer W.U., Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J. Physiol. 2006, 577:263-280.
134. Takahashi K.A., Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 2006, 139:795-802.
135. Tanimura A., Yamazaki M., Hashimotodani Y., Uchigashima M., Kawata S., Abe M., Kita Y., Hashimoto K., Shimizu T., Watanabe M., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 2010, 65:320-327.
136. Tanimura A., Uchigashima M., Yamazaki M., Uesaka N., Mikuni T., Abe M., Hashimoto K., Watanabe M., Sakimura K., Kano M. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc. Natl. Acad. Sci. USA 2012, 109:12195-12200.
137. Tóth A., Boczán J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., Blumberg P.M. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 2005, 135:162-168.
138. Tsetsenis T., Younts T.J., Chiu C.Q., Kaeser P.S., Castillo P.E., Südhof T.C. Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning. Proc. Natl. Acad. Sci. USA 2011, 108:14300-14305.
139. Uchigashima M., Yamazaki M., Yamasaki M., Tanimura A., Sakimura K., Kano M., Watanabe M. Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J. Neurosci. 2011, 31:7700-7714.
140. van Beugen B.J., Nagaraja R.Y., Hansel C. Climbing fiber-evoked endocannabinoid signaling heterosynaptically suppresses presynaptic cerebellar long-term potentiation. J. Neurosci. 2006, 26:8289-8294.
141. van der Stelt M., Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 2005, 77:111-122.
142. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
143. Vandevoorde S., Lambert D.M. The multiple pathways of endocannabinoid metabolism: a zoom out. Chem. Biodivers. 2007, 4:1858-1881.
144. Varma N., Carlson G.C., Ledent C., Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 2001, 21:RC188.
145. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2010, 30:11188-11196.
146. Wang W., Sun D., Pan B., Roberts C.J., Sun X., Hillard C.J., Liu Q.S. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010, 35:2249-2261.
147. Wang M., Hill M.N., Zhang L., Gorzalka B.B., Hillard C.J., Alger B.E. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J. Psychopharmacol. (Oxford) 2012, 26:56-70.
148. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
149. Wilson R.I., Kunos G., Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 2001, 31:453-462.
150. Wu D.F., Yang L.Q., Goschke A., Stumm R., Brandenburg L.O., Liang Y.J., Höllt V., Koch T. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 2008, 104:1132-1143.
151. 2 receptors modulate cocaine's actions in mice. Nat. Neurosci. 2011, 14:1160-1166.
152. Yasuda H., Huang Y., Tsumoto T. Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus. Proc. Natl. Acad. Sci. USA 2008, 105:3106-3111.
153. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 2006, 26:4740-4751.
154. Yoshida T., Uchigashima M., Yamasaki M., Katona I., Yamazaki M., Sakimura K., Kano M., Yoshioka M., Watanabe M. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc. Natl. Acad. Sci. USA 2011, 108:3059-3064.
155. Yoshino H., Miyamae T., Hansen G., Zambrowicz B., Flynn M., Pedicord D., Blat Y., Westphal R.S., Zaczek R., Lewis D.A., Gonzalez-Burgos G. Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J. Physiol. 2011, 589:4857-4884.
156. Zhang L., Alger B.E. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 2010, 30:5724-5729.
157. Zhong P., Pan B., Gao X.P., Blankman J.L., Cravatt B.F., Liu Q.S. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. J. Physiol. 2011, 589:4847-4855.
158. Zhu P.J., Lovinger D.M. Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J. Neurophysiol. 2007, 97:4386-4389.
159. Zhu P.J., Lovinger D.M. Developmental alteration of endocannabinoid retrograde signaling in the hippocampus. J. Neurophysiol. 2010, 103:1123-1129.
160. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sørgård M., Di Marzo V., Julius D., Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400:452-457.